Diabefarm - magani ne don rage sukarin jini

Tare da nau'in ciwon sukari na 2, jimawa ko daga baya akwai rashi na endogenous, shine, ana samarwa a cikin jiki, insulin. Diabefarm, wani kamfanin Rasha ne wanda kamfanin Pharmakor na St. Petersburg ya kera, zai iya magance wannan matsalar. Ya zama na shirye-shiryen sulfonylurea kuma yana daya daga cikin aminci a cikin wannan rukuni.

Diabefarma mai aiki, glycoslazide, an lullube shi a cikin allunan tare da sakewar da aka sake, wanda ke ba da damar cimma daidaituwa na miyagun ƙwayoyi a cikin jini kuma hakan zai iya rage haɗarin hauhawar jini. Ba shi yiwuwa a fitar da dukkanin abubuwan da ke haifar da rashin daidaituwa a lokacin jiyya tare da kowane irin abubuwan da suka samo asali na sulfonylurea.

Ka'idar magani

Ayyukan kwayoyi da aka yi amfani da su a cikin sukari ya kamata ya zama daidai da pathophysiology na wannan cuta. Rashin lafiyar carbohydrate na farko ana bayyana shi sau da yawa a cikin juriya na insulin, saboda haka an tsara marasa lafiya allunan da nufin rage shi. Mafi inganci magani a wannan batun shine metformin (Siofor, Glucofage da analogues). Hakanan, ana nuna masu haƙuri ta hanyar haɓaka gluconeogenesis: hanta tana fitowa ta hanta a cikin mafi yawa fiye da da. Metformin kuma ya sami nasarar magance wannan take hakkin.

A cikin mataki na biyu na ciwon sukari, raguwa a cikin aikin ƙwayar cuta yana farawa. Na farko, canje-canje suna faruwa a farkon kashi na ɓoye: ƙimar sakin insulin a cikin jini ya ragu bayan an cika glucose a ciki. A hankali, kashi na farko gaba daya ya shuɗe, kuma yayin rana ana kiyaye yawan sukarin jini a matakin da ya hauhawa koyaushe. A wannan lokacin, za a iya rage yawan sukari na jini ta hanyoyi guda biyu: ko dai a rage yawan cin abinci na carbohydrates ta amfani da tsayayyen abincin da yake kyauta daga carbohydrates, ko kuma aci abincin da ya gabata kuma a ƙara magungunan Diabefarm ko analogues ɗin a tsarin kulawa.

Diabefarm yana shafar ƙwayoyin ƙwayar ƙwayar ƙwayar cuta, suna tilasta su samar da insulin. Zai iya dawo da kashi na farko da ya ɓace, saboda wanda lokacin tsakanin sakin glucose ya shiga cikin jini da farkon ɓoyewar ƙwayar ya ragu, kuma glycemia bayan cin abinci ya ragu. Baya ga babban aikin, Diabefarm yana da ikon yaƙar juriya na insulin, amma ƙasa da tasiri fiye da metformin. Don kyautata raunin cutar sankara, waɗannan magunguna an wajabta su azaman biyu.

Ciwon sukari da hauhawar jini zai zama abin da ya wuce

• Normalization na sukari -95%
• Cirewa kan jijiyoyin mara wuya - 70%
• Cire zuciyar mai karfin zuciya -90%
• Rabu da cutar hawan jini - 92%
• Increasearuwar kuzarin rana, inganta bacci da dare -97%

Hakanan a cikin maganin, an samo ƙarin aiki kuma an nuna shi a cikin umarnin, ba shi da alaƙa da raguwar sukari, amma yana da matukar amfani ga marasa lafiya da ciwon sukari. Magungunan yana hana haɓakar ƙwayar jini a cikin tasoshin jini, yana inganta hanyoyin halitta na ajiyar su. Wannan tasirin yana ba ku damar rage girman ci gaban retinopathy da sauran rikitarwa na jijiyoyin jiki. A cikin cutar sankara, shan Diabefarm yana haifar da raguwar matakin furotin a cikin fitsari.

Alamu don amfani

Diabefarm an wajabta shi ne kawai ga waɗancan marasa lafiya waɗanda suka adana kwayar insulin, amma bai isa ba don sukarin jini na al'ada. Masu ciwon sukari na 2 suna biyan waɗannan buƙatu a matsakaicin shekaru 5 bayan farkon cutar. Tabbatar da rashin ƙwayar homonin na iya gwajin jini ga C-peptide ko insulin.

Yayin magani tare da miyagun ƙwayoyi, ƙuntatawa na abinci ya zama tilas: tebur na 9 ko sama da ƙarancin abincin carb. Ya kamata a cire kayan sawa kuma abubuwan carbohydrates iyakance daga wasu abinci: hatsi, wasu kayan lambu da 'ya'yan itatuwa. Hakanan, ana nuna marasa lafiya aiki na yau da kullun. Idan rage cin abinci, motsa jiki, metformin da Diabefarm a cikin matsakaicin adadin ba su rage yawan sukari, masu ciwon sukari suna buƙatar ilimin insulin.

Nazarin Gwanaye

Arkady Alexandrovich

Endocrinologist tare da gwaninta

Tambaye gwani a tambaya

A cikin ciwon sukari na nau'in farko, Ba a ba da umarnin Diabefarm ba, tun da marasa lafiya ba su da ƙwayoyin beta, wanda ke nufin cewa ba shi yiwuwa a maido da insulin insulin.

Fitar saki da sashi

A cikin rajistar magunguna, ana rajista da miyagun ƙwayoyi a cikin nau'ikan 2: Diabefarm da Diabefarm MV.

Nau'in da aka saba (sakin nan da nan) nau'i ne da aka saki, yana da wahala a same shi a cikin kantin magani. Abu ne mai sauki a rarrabe magunguna a kashi 80 na MG.

Diabefarm MV yana da sashi na 30 kawai. Wannan magani ne wanda aka gyara ko tsawa. Wannan fom ɗin yana ba ku damar rage yawan sarrafawa da kashi, kawar da tasirin fushin abu mai aiki a cikin narkewa, rage haɗarin sakamako masu illa. Dangane da umarnin, yawan haɗuwar gliclazide ya kasance kusan kullun a cikin kullun bayan shan Diabefarma MV. A cewar masu ciwon sukari, sabon maganin ba shi da wataƙila zai iya haifar da ƙin jini fiye da wanda ya riga ya faɗi. Likitoci sun yarda da marasa lafiya, bincike ya tabbatar da fa'idar karin gliclazide akan al'ada.

Umarnin don amfani

Suna shan Diabefarm MV 30 a lokaci guda kamar karin kumallo. Tare da farkon amfani da miyagun ƙwayoyi, kuna buƙatar tsara abincinku bisa ga shawarar likita: ku ci sau da yawa kaɗan kaɗan, kada ku tsallake abinci, rarraba carbohydrates a ko'ina cikin yini.

Yadda za a fara jiyya:

1. Ba tare da la'akari da matakin hyperglycemia ba, Diabefarm yana farawa da kwamfutar hannu 1 na 30 MG. Don makonni 2 masu zuwa, an hana kara yawan kwayoyin cutar. Wannan lokacin wajibi ne don aiwatar da aikin Glyclazide don buɗewa, jikin yana da lokaci don amfani da magani.
2. Idan sukari bai koma al'ada ba, ana kara kashi zuwa 60 MG. Dangane da sake dubawa, wannan sashi ya isa ga yawancin masu ciwon sukari.
3. Idan ya cancanta, za a iya ƙara hankali zuwa 120 MG (allunan 4), amma babu ƙari.

A cikin tsofaffi, marasa lafiya da ke da rauni zuwa ga ƙarancin ƙarancin koda, Diabefarm yana ramawa ga masu ciwon sukari kamar yadda yakamata, don haka basa buƙatar gyara sashi. Asingara yawan ƙwayar cutar Diabefarm ko wasu wakilai na hypoglycemic da aka ɗauka tare da ita ya kamata a haɗe tare da saka idanu akai-akai na glucose jini, saboda a wannan lokacin haɗarin cutar hypoglycemia ya fi girma. Umarnin don amfani yana ba da izinin yin maganin tare da metformin, acarbose da insulin.

Side effects na magani

Babban haɗarin shan Diabefarm shine hypoglycemia. Mafi sau da yawa, yana haɗuwa tare da alamu mai tsanani wanda ya saba da duk wanda ke da ciwon sukari: rawar jiki, yunwar, ciwon kai, gajiya, rashin jin daɗi ko rashin damuwa, farin ciki.

Dalilin rashin karfin jini na iya zama:

1. Doaukar yawan magunguna ko gudanar da aikinta tare da kwayoyi masu kama da wannan: sulfonylurea, Dhib-4 inhibitors, da kuma GLP-1 analogues.
2. Kurakurai a cikin abinci mai gina jiki: Abin tsallake abinci ko raguwa mai yawa a cikin adadin carbohydrates ba tare da rage yawan matakan Diabefarm ba.
3. Kudin shiga tare da wasu kwayoyi wadanda ke inganta tasirin gliclazide: antihypertensive, antifungal, anti-tarin fuka, hormonal, anti-mai kumburi.

Kamar kowane magani, Diabefarm na iya tayar da jijiyar abinci. Nausea, zawo, jin nauyi a cikin ciki za'a iya guje masa idan kun sha maganin tare da abinci, kamar yadda umarni suke ba ku. Hakanan akwai ƙananan haɗarin rashin lafiyan, yawanci kurji da itching. Idan wata rashin lafiyan ta faru ga Diabefarm, da alama irin tasirin da ake yiwa duk magunguna daga wannan rukunin yana da yawa.

Lokacin da aka sha shi da giya, amsa disulfiram-kamar zai yuwu. Wannan shi ne tarawa a jikin kayan lalata na ethanol, wanda ke nuna kansa a cikin nau'i na amai, matsalolin numfashi, hauhawar zuciya, da raguwa cikin matsin lamba. Da yawan giya da aka bugu, da mafi tsananin bayyanar cututtuka. Irin wannan halayen na iya bunkasa a kowane lokaci. Idan da zarar giya tare da Diabefarm bai kawo lahani ba, wannan baya nufin cewa lokaci na gaba bazai sami matsala ba.

Ga Diabefarm an ba shi contraindicated

Yardajewa:

• hypersensitivity to gliclazide ko ƙungiyar analogues;
• lalacewa na aiki ko aikin hepatic;
• karancin ƙwayar hanji;
• tsawon lokacin kulawa da mummunan rikice-rikice na ciwon sukari, raunin raunin da ya faru, ƙonewa da sauran yanayin barazanar rayuwa;
• leukopenia;
• ciki, hepatitis B;
• marasa lafiya 'yan kasa da shekara 18.

Yadda za'a maye gurbin

Diabefarm yana daya daga cikin abubuwan da ke tattare da cutar Diabeton. An samar da asali a Faransa, farashinsa ya ninka sau 2-3 fiye da na shirye-shiryen cikin gida tare da abun guda ɗaya. Hakanan, ilimin halittar Diabeton da analogues na Diabefarm sune:

• Gliclazide MV, MV Pharmstandard, SZ, Canon, Akos;
• Golda MV;
• Gliklada;
• Diabetalong;
• Glidiab MV;
• Diabinax;
• Diatics.

Dangane da sake dubawa, mafi mashahuri daga wannan jerin su ne ainihin masu ciwon sukari, da kuma Glyclazide na Rasha da Glidiab.

Neman Masu haƙuri